ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,164Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 2456

$652K Total Retail Price of All Prescriptions

Rank: 127 out of 2456

360 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 13,482 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 850 765 1 1
WARFARIN SODIUM 723 691 2 9
METOPROLOL TARTRATE 644 563 3 10
FAMOTIDINE 639 566 4 84
SIMVASTATIN 587 456 5 2
LEVOTHYROXINE SODIUM 561 502 6 4
OMEPRAZOLE 530 402 7 3
ATENOLOL 402 340 8 6
DONEPEZIL HCL 364 361 9 23
CITALOPRAM HBR 340 309 10 14
AMLODIPINE BESYLATE 280 280 11 5
FUROSEMIDE 273 263 12 8
METOPROLOL SUCCINATE 264 228 13 13
GABAPENTIN 264 238 13 16
TRAZODONE HCL 262 243 15 17
HYDROCHLOROTHIAZIDE 190 174 16 7
MIRTAZAPINE 186 162 17 29
NAMENDA 181 181 18 42
ATORVASTATIN CALCIUM 165 121 19 12
POTASSIUM CHLORIDE 160 147 20 33
DIOVAN 158 146 21 26
SERTRALINE HCL 154 143 22 21
QUETIAPINE FUMARATE 141 139 23 47
DIGOXIN 131 131 24 49
DOXAZOSIN MESYLATE 129 129 25 71
LANTUS 126 110 26 44
BUSPIRONE HCL 125 107 27 157
CELEBREX 123 120 28 127
PREDNISONE 112 110 29 39
FLUOXETINE HCL 111 76 30 45
CYCLOBENZAPRINE HCL 108 67 R 31 77
ZOLPIDEM TARTRATE 102 99 32 28
BISOPROLOL-HYDROCHLOROTHIAZIDE 100 100 33 223
OXYCODONE-ACETAMINOPHEN 97 77 S2 34 35
METFORMIN HCL 97 83 34 11
IPRATROPIUM-ALBUTEROL 94 94 36 85
RISPERIDONE 93 81 37 50
TRAMADOL HCL 84 62 38 24
CARISOPRODOL 83 38 R 39 179
SINGULAIR 83 81 39 149
DIVALPROEX SODIUM 81 81 41 51
PROPRANOLOL HCL 79 55 42 108
ALBUTEROL SULFATE 77 77 43 165
TAMSULOSIN HCL 76 67 44 32
DILTIAZEM 24HR ER 75 75 45 78
LOSARTAN POTASSIUM 74 58 46 18
RANITIDINE HCL 73 73 47 31
DILTIAZEM 24HR CD 72 72 48 113
FLUTICASONE PROPIONATE 67 31 49 30
CLOPIDOGREL 66 66 50 55
ALENDRONATE SODIUM 65 65 51 19
VENLAFAXINE HCL ER 64 64 52 92
CRESTOR 62 62 53 25
AMITRIPTYLINE HCL 62 62 R 53 83
LYRICA 62 43 53 199
CARBIDOPA-LEVODOPA 62 62 53 82
GENERLAC 62 62 53 142
NIFEDIPINE ER 61 48 58 61
POLYETHYLENE GLYCOL 3350 60 60 59 64
FLOVENT HFA 58 38 60 104
LACTULOSE 57 35 61 88
SEROQUEL 56 54 62 102
PROAIR HFA 56 38 62 22
SYNTHROID 55 49 64 118
OXYCODONE HCL 54 52 S2 65 38
SPIRIVA 53 49 66 43
LIPITOR 50 46 67 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.